- CA$17.62m
- CA$15.02m
- CA$9.63m
Brief: Ceapro Reports Qtrly Sales of C$2.1 Mln
Brief: Ceapro Gets Approval From Health Canada To Start Human Clinical Study
Brief: Ceapro Reports Q2 Shr $0.00
Brief: Ceapro Inc. Reports Q2 Sales C$2.7 Mln
Brief: Ceapro Q1 Net Loss Per Common Earnings Per Share Of $0.00
Brief: Ceapro Inc. Provides Corporate Update
Brief: Ceapro says qtrly earnings per share $0.00
Brief: Ceapro qtrly earnings per share $0.00
Brief: Ceapro qtrly earnings per share $0.01
Brief: Ceapro Qtrly EPS $ 0.02
Brief: Ceapro announces brokered private placement
Brief: Ceapro reports Q1 earnings per share $0.02
Brief: Ceapro announces renewal of license and distribution agreement with Symrise